September Issue of Best’s Review Ranks Top Mutuals and More

AM Best announced that its September Best’s Review issue will publish rankings of the top 25 U.S. property/casualty mutual insurers, life/health mutual companies, global reinsurance groups, and selected life-insurance operating metrics. The release contains no financial results, outlook changes, or material market-moving developments.

Analysis

This is a publication/calendar item rather than a new underwriting, capital, pricing, or regulatory datapoint. The rankings could become a useful screening input for mutual insurers, but they do not independently establish changes in book value growth, reserve adequacy, catastrophe exposure, or distributable capital; there is no immediate public-equity read-through.

The potentially actionable second-order use is private-market and credit diligence: relative movement in life-policy size, lapse ratios, and group-life in-force can flag distribution quality or adverse-selection pressure before it appears in statutory filings. For P/C mutuals, shifts in D&O monoline scale may identify firms carrying disproportionate long-tail reserve and social-inflation exposure, but the underlying ranking tables and multi-year trend data are required before forming a view.

No trade is warranted on the release itself. Over the next 1-3 months, monitor whether any large mutual insurer exhibits deteriorating lapse experience, rapid group-life growth without commensurate pricing, or D&O premium concentration; those signals could matter for reinsurers such as RNR, RGA, and AEG, as well as public peers competing for similar risks. A meaningful thesis would require confirmation in statutory statements, AM Best rating actions, or earnings guidance rather than rank changes alone.

Key Decisions for Investors

• No immediate position: treat the ranking release as an information-gathering event, not a catalyst.
• Create a watchlist around RGA, RNR and AEG for 1-3 month follow-up; investigate any disclosed counterparty concentration to mutual life, group-life, or D&O writers before taking exposure.
• Request the underlying historical tables and compare rank changes with statutory capital ratios, reserve development, lapse trends and reinsurance utilization. Escalate only if rank gains coincide with worsening capital quality or unusually rapid premium growth.
• For listed insurers with meaningful D&O exposure, use the next quarterly reserve-development disclosures as the falsification point: stable favorable development and unchanged combined-ratio guidance would negate a bearish long-tail-reserve concern.